Acasti Pharma Inc. (ACST)

NASDAQ: ACST · Real-Time Price · USD

3.37

0.13 (4.01%)

At close: Oct 25, 2024, 8:00 PM

4.01% (1D)

Bid	n/a
Market Cap	34.17M
Revenue (ttm)	n/a
Net Income (ttm)	-11.89M
EPS (ttm)	-1.43
PE Ratio (ttm)	-2.3566433566433567
Forward PE	n/a
Analyst	Strong Buy

Ask	n/a
Volume	27,682
Avg. Volume (20D)	33,247
Open	3.43
Previous Close	3.24
Day's Range	3.20 - 3.45
52-Week Range	1.98 - 3.60
Beta	1.52

About ACST

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada....

[Read more]

Industry Biotechnology

Sector Healthcare

IPO Date Feb 7, 2012

Employees 32

Stock Exchange NASDAQ

Ticker Symbol ACST

Website https://www.acastipharma.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for ACST stock is "Strong Buy." The 12-month stock price forecast is $10, which is an increase of 196.74% from the latest price.

Stock Forecasts

Why Price Moved

7 months ago

+19.53%

Acasti Pharma shares are trading higher after the ... Unlock content with Pro Subscription

News

9 months ago · zacks.com

Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year?

Here is how Acasti Pharma (ACST) and Cigna (CI) have performed compared to their sector so far this year.

10 months ago · investorplace.com

Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024

As the main stock indices like the S&P 500 and Nasdaq continue to climb, penny stocks are becoming attractive for those seeking significant returns. Despite their reputation for extreme price fluctuat...

11 months ago · investorplace.com

The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom

Novavax (NASDAQ: NVAX ) stock was among the laggards in the race for the vaccine against COVID-19. Unsurprisingly, NVAX stock plunged from highs of $320 in 2021 to recent lows of $3.5.

2 years ago · zacks.com

Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year?

Here is how Acasti Pharma (ACST) and Autolus Therapeutics PLC Sponsored ADR (AUTL) have performed compared to their sector so far this year.

2 years ago · seekingalpha.com

Acasti Pharma Inc. (ACST) Q3 2023 Earnings Call Transcript

Acasti Pharma Inc. (NASDAQ:ACST ) Q3 2023 Earnings Conference Call February 14, 2023 1:00 PM ET Company Representatives Jan D'Alvise - President, Chief Executive Officer Brian Ford - Chief Financial O...

2 years ago · pennystocks.com

Best Penny Stocks To Buy Now? 4 Stocks Under $4 To Watch

Penny stocks to watch this week. The post Best Penny Stocks To Buy Now?

2 years ago · seekingalpha.com

Acasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcript

Acasti Pharma Inc. (NASDAQ:ACST ) Q2 2023 Earnings Conference Call November 14, 2022 1:00 PM ET Company Participants Robert Blum - Lytham Partners, IR Jan D'Alvise - President & CEO Brian Ford - CFO P...

2 years ago · benzinga.com

Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine

Acasti Pharma Inc's (NASDAQ: ACST) pharmacokinetic (PK) bridging study with IV GTX-104, its lead drug candidate for Subarachnoid Hemorrhage (SAH), met all its planned study endpoints. The study's pri...